{
    "2020-05-29": [
        [
            {
                "time": "",
                "original_text": "日媒：华为已储备够用一两年的芯片，含英特尔的尖端产品；个别中国公民持伪",
                "features": {
                    "keywords": [
                        "华为",
                        "芯片",
                        "储备",
                        "英特尔"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "下周197亿市值限售股解禁，环比增加42.82% 解禁",
                "features": {
                    "keywords": [
                        "限售股",
                        "解禁",
                        "市值"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物实控人因离婚拟分割公司23.99%股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "实控人",
                        "离婚",
                        "股份分割"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：实控人因离婚分割逾235亿元市值股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "实控人",
                        "离婚",
                        "股份分割",
                        "市值"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【国金研究】生物制药行业深度研究：生物制品行业年报一季度回顾及批签发分析",
                "features": {
                    "keywords": [
                        "生物制药",
                        "行业研究",
                        "年报",
                        "一季度",
                        "批签发"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "平均浮盈36.13%，公募大举进军定增市场",
                "features": {
                    "keywords": [
                        "公募基金",
                        "定增市场",
                        "浮盈"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}